Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serhat Ünal

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Balkan Medical Journal|February 29, 2020
Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infectionsMurat Sayan, Müge Özgüler, Figen Sarıgül Yıldırım, et al.
Turkish Journal of Medical Sciences|November 3, 2022
Remdesivir treatment for patients with moderate to severe COVID-19İmran Hasanoğlu, Rahmet Güner, İlhami Çelik, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|January 27, 2025
Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19Dorina Esendagli, Nuran Sarı, Sıla Akhan, et al.
The New England Journal of Medicine|December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineFernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 MonthsStephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Rheumatology International|September 13, 2021
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controlsAli Mert, Haluk Vahaboğlu, Ferhat Arslan, et al.
Critical Care (London, England)|January 10, 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialMarius Trøseid, José R Arribas, Lambert Assoumou, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Balkan Medical Journal|February 29, 2020
Molecular Identification of HIV-1 in the Presence of Hepatitis B Virus and Hepatitis C Virus Co-infectionsMurat Sayan, Müge Özgüler, Figen Sarıgül Yıldırım, et al.
Turkish Journal of Medical Sciences|November 3, 2022
Remdesivir treatment for patients with moderate to severe COVID-19İmran Hasanoğlu, Rahmet Güner, İlhami Çelik, et al.
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|January 27, 2025
Inhaled Aviptadil Is a New Hope for Recovery of Lung Damage due to COVID-19Dorina Esendagli, Nuran Sarı, Sıla Akhan, et al.
The New England Journal of Medicine|December 10, 2020
Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineFernando P Polack, Stephen J Thomas, Nicholas Kitchin, et al.
The New England Journal of Medicine|September 15, 2021
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 MonthsStephen J Thomas, Edson D Moreira, Nicholas Kitchin, et al.
Rheumatology International|September 13, 2021
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controlsAli Mert, Haluk Vahaboğlu, Ferhat Arslan, et al.
Critical Care (London, England)|January 10, 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trialMarius Trøseid, José R Arribas, Lambert Assoumou, et al.
Pageof 6